We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

152 hedge funds and large institutions have $315M invested in NEVRO CORP. in 2024 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 59 increasing their positions, 45 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 45

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 31

1% less funds holding

Funds holding: 153152 (-1)

42% less capital invested

Capital invested by funds: $539M → $315M (-$224M)

97% less call options, than puts

Call options by funds: $426K | Put options by funds: $13M

Holders
152
Holders Change
-1
Holders Change %
-0.65%
% of All Funds
2.2%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
31
Increased
59
Reduced
45
Closed
31
Calls
$426K
Puts
$13M
Net Calls
-$12.5M
Net Calls Change
+$430K
Name Holding Trade Value Shares
Change
Change in
Stake
HF
76
HRT Financial
New York
$253K -$538K -50,456 -63%
DCM
77
DAFNA Capital Management
California
$236K
Voloridge Investment Management
78
Voloridge Investment Management
Florida
$234K -$368K -34,558 -55%
American Century Companies
79
American Century Companies
Missouri
$227K +$20.3K +1,907 +8%
JRP
80
Jasper Ridge Partners
California
$219K
SPA
81
Sherbrooke Park Advisers
New York
$217K +$275K +25,811 New
OR
82
Olympiad Research
Connecticut
$211K +$267K +25,046 New
XT
83
XTX Topco
Cayman Islands
$208K +$121K +11,323 +85%
Verition Fund Management
84
Verition Fund Management
Connecticut
$203K -$87.4K -8,200 -25%
Legal & General Group
85
Legal & General Group
United Kingdom
$202K -$137K -12,889 -35%
PCM
86
Prelude Capital Management
New York
$202K +$256K +24,044 New
MIM
87
MetLife Investment Management
New Jersey
$175K +$19.4K +1,821 +10%
Susquehanna International Group
88
Susquehanna International Group
Pennsylvania
$169K +$49.1K +4,605 +30%
Franklin Resources
89
Franklin Resources
California
$168K +$26.4K +2,478 +14%
CF
90
Corebridge Financial
Texas
$164K +$207K +19,455 New
ET
91
Entropy Technologies
New York
$158K +$200K +18,783 New
AI
92
Atom Investors
Texas
$155K -$18.4K -1,724 -9%
Mirae Asset Global ETFs Holdings
93
Mirae Asset Global ETFs Holdings
Hong Kong
$151K +$191K +17,897 New
Wells Fargo
94
Wells Fargo
California
$139K +$41.4K +3,880 +31%
Manulife (Manufacturers Life Insurance)
95
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$125K +$17.1K +1,600 +12%
Janus Henderson Group
96
Janus Henderson Group
United Kingdom
$123K -$1.93K -181 -1%
New York State Common Retirement Fund
97
New York State Common Retirement Fund
New York
$122K +$1.23K +115 +0.8%
UBS Group
98
UBS Group
Switzerland
$118K -$267K -25,006 -64%
VOYA Investment Management
99
VOYA Investment Management
Georgia
$105K +$10.7K +1,008 +9%
DWT
100
Dorsey & Whitney Trust
South Dakota
$97.3K -$427 -40 -0.3%

NVRO Hedge Fund Activity: Q2 2024 in Review

152 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q2 2024, worth a combined $315M — down 42% from $539M a quarter earlier.

Fund positioning in NVRO was balanced in Q2 2024: 31 funds opened new positions, 31 closed out, 59 added to existing stakes and 45 trimmed.

The largest buyer was ArrowMark Colorado Holdings, adding an estimated $15.9M. The largest seller was Principal Financial Group, exiting entirely with an estimated $10.3M sold.

  • 152 institutional investors held NEVRO CORP. (NVRO) as of Q2 2024, down from 153 in Q1 2024.
  • Funds reported $315M of NEVRO CORP. stock for Q2 2024, down 42% quarter-over-quarter.
  • 31 funds opened new NEVRO CORP. positions in Q2 2024 and 31 closed out, a net change of 0 holders.
  • The largest NEVRO CORP. buyer in Q2 2024 was ArrowMark Colorado Holdings, an estimated $15.9M added.
  • The largest NEVRO CORP. seller in Q2 2024 was Principal Financial Group, an estimated $10.3M sold.

Based on aggregated 13F filings for Q2 2024.